October 1, 2021Open Access

Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

NPC patients with low levels of CD19+ B cells or CD4+ T cells before treatment have a poor prognosis. In addition, chemoradiotherapy may reduce the body's immune function in NPC patients.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Shen et al. (Fri,) studied this question.

synapsesocial.com/papers/69d77e9af44a16d01ef31645 https://doi.org/https://doi.org/10.2147/cmar.s334094

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1CD4 lymphopenia to identify end-of-life metastatic cancer patients2012 · 38 citations
2Characteristics of T lymphocyte subpopulations2013 · 11 citations
3Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy2016 · 192 citations
4Pre-treatment Serum Lactate Dehydrogenase Predicts Distant Metastasis and Poor Survival in Nasopharyngeal Carcinoma2019 · 32 citations
5The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system2017 · 29 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo